Factors that determine the antiviral efficacy of HCV-specific CD8 + T cells ex vivo

Gastroenterology

Volumn 144, Issue 2, 2013, Pages 426-436

  Seigel, Bianca ^a,b   Bengsch, Bertram ^a,b   Lohmann, Volker ^c   Bartenschlager, Ralf ^c   Blum, Hubert E ^a   Thimme, Robert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antiviral therapy; Immune response; Liver disease; T cell exhaustion

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; PROGRAMMED DEATH 1 RECEPTOR; ANTIVIRUS AGENT; INTERLEUKIN 7 RECEPTOR ALPHA; PDCD1 PROTEIN, HUMAN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; EX VIVO STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; VIRAL CLEARANCE; VIRUS INHIBITION; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; CELLULAR IMMUNITY; COCULTURE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; VIRAL LOAD; VIRUS REPLICATION;

EID: 84881498596     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.10.047     Document Type: Article

References (40)

1. Cooper S, Erickson AL, Adams EJ, et al.. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10: 439-449.
2. Lechner F, Wong DK, Dunbar PR, et al.. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000;191:1499-1512.
3. Thimme R, Oldach D, Chang KM, et al.. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001;194:1395-1406.
4. Klenerman P, Thimme R. T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 2012;61:1226-1234.
5. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009;119:1745-1754.
6. Gruener NH, Lechner F, Jung MC, et al.. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.
7. Spangenberg HC, Viazov S, Kersting N, et al.. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 2005;42:828-837.
8. Wedemeyer H, He XS, Nascimbeni M, et al.. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-3458.
9. Golden-Mason L, Palmer B, Klarquist J, et al.. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007;81:9249-9258.
10. Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, et al.. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 2008;82:3154-3160.
11. Nakamoto N, Kaplan DE, Coleclough J, et al.. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008;134:1927-1937, 1937 e1-2.
12. Radziewicz H, Ibegbu CC, Fernandez ML, et al.. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007;81:2545-2553.
13. Schlaphoff V, Lunemann S, Suneetha PV, et al.. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 2011;7:e1002045.
14. Urbani S, Amadei B, Tola D, et al.. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006;80:11398-11403.
15. McMahan RH, Golden-Mason L, Nishimura MI, et al.. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010;120:4546-4557.
16. Nakamoto N, Cho H, Shaked A, et al.. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009;5:e1000313.
17. Urbani S, Amadei B, Tola D, et al.. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 2008;48:548-558.
18. Bengsch B, Seigel B, Ruhl M, et al.. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010;6:e1000947.
19. Kasprowicz V, Kang YH, Lucas M, et al.. Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution. J Virol 2010;84:1656-1663.
20. Rutebemberwa A, Ray SC, Astemborski J, et al.. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 2008;181:8215-8225.
21. Jo J, Aichele U, Kersting N, et al.. Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology 2009;136:1391-1401.
22. Bengsch B, Spangenberg HC, Kersting N, et al.. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 2007;81:945-953.
23. Neumann-Haefelin C, Timm J, Spangenberg HC, et al.. Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection. Hepatology 2008;47:1824-1836.
24. Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay. Clin Lab Med 2007;27:469-485.
25. Bengsch B, Thimme R. CD8+ T-cell differentiation in chronic HCV infection. Future Virol 2011;6:249-258.
26. Radziewicz H, Ibegbu CC, Hon H, et al.. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 2008;82:9808-9822.
27. Penna A, Pilli M, Zerbini A, et al.. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007;45:588-601.
28. Frese M, Schwarzle V, Barth K, et al.. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002;35:694-703.
29. Jo J, Bengsch B, Seigel B, et al.. Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. J Hepatol 2012;57:9-16.
30. Radziewicz H, Hanson HL, Ahmed R, et al.. Unraveling the role of PD-1/PD-L interactions in persistent hepatotropic infections: potential for therapeutic application? Gastroenterology 2008;134: 2168-2171.
31. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012;12: 180-190.
32. Leone A, Picker LJ, Sodora DL. IL-2, IL-7 and IL-15 as immunomodulators during SIV/HIV vaccination and treatment. Curr HIV Res 2009;7:83-90.
33. Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330-342.
34. Chevalier MF, Julg B, Pyo A, et al.. HIV-1-specific interleukin-21+CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol 2011; 85:733-741.
35. Williams LD, Bansal A, Sabbaj S, et al.. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol 2011;85:2316-2324.
36. Accapezzato D, Francavilla V, Paroli M, et al.. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113:963-972.
37. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007;19:408-415.
38. Abdel-Hakeem MS, Bedard N, Badr G, et al.. Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol 2010;84:10429-10435.
39. Missale G, Pilli M, Zerbini A, et al.. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection. Gut 2012;61:1076-1084.
40. Badr G, Bedard N, Abdel-Hakeem MS, et al.. Early interferon therapy for hepatitis C virus infection rescues polyfunctional, longlived CD8+ memory T cells. J Virol 2008;82:10017-10031.